300149.SZ
ChemPartner PharmaTech Co., Ltd.
SZSE · M 科研服务 · CN
CNY 9.70
−6.55%Sep 16, 2026, 09:32 UTC
ChemPartner PharmaTech's September 2024 strategic cooperation framework agreement with Universiti Kebangsaan Malaysia and PHARMA MEDICAL SDN BHD. in drug discovery and development expired with no concrete progress and terminated automatically.
Source:Sep 15, 2026, 11:57 UTC
ChemPartner PharmaTech received investor research on September 15, 2026, from investors participating online in the 2026 Guangdong Province investor collective reception day event; Chairman and CEO WOO SWEE LIAN, CFO Zha Yinqun, and Board Secretary Wu Wenhua attended.
Source:Aug 31, 2026, 14:57 UTC
Ruizhi Pharmaceutical announced that its Lingang base is in a capacity expansion phase, with its GMP pilot workshop entering trial production, which will support increasing business volume.
Source: